Dr. Farukh Arjmand
My Social Links

Dr. Farukh Arjmand

Professor
Aligarh Muslim University, India

Highest Degree
Ph.D. in Chemistry from Aligarh Muslim University, Aligarh, India

Share this Profile

Biography

Dr. Farukh Arjmand is currently working as Professor at Aligarh Muslim University, India. She has completed her Masters and PhD in Chemistry from Aligarh Muslim University, Aligarh and later has joined her services as Lecturer in 1994 in A.M.U. Dr Arjmand has research experience of 23 years in the specialization area of Bioinorganic Chemistry. Her research focus is on Medicinal Inorganic Chemistry. She works on Design and Synthesis of Chiral metal-based Antitumor Chemotherapeutic Drug entities and in vitro interaction studies of Metal-based compounds with Biomolecules viz, DNA, RNA and Nucleotides. She has published more than 104 research articles pertinent to her specialization area in the peer reviewed journals of international repute. She has contributed 42 articles to conferences/ symposium and has two patents. Dr. Arjmand has successfully guided 11 PhD and 2 M. Phil students. She has successfully completed 5 major research projects as Principal Investigator. She has visited many countries (China, USA, Egypt) for academic pursuits. She has joint research collaborations with national and international research institutes such as IIT Kharagpur, IICT, Hyderabad and ACTREC, Mumbai (India) USTC, China, USM, Malaysia and Materials Chemistry Laboratory Oujda, Morocco and Institut de Physique de Rennes - UMR 6251, Universite de Rennes 1, France. She is life member of Chemical Research Society of India, Indian Council of Chemists, Indian Society of Chemists and Biologists, DNA Society of India, Kolkata, and annual member of American Chemical Society. She also delivered 6 invited lectures at different institutes. She is also serving as reviewer for 14 journals.

Area of Interest:

Chemistry
100%
Heterobimetallic Complexes
62%
Synthesis
90%
Protein Interactions
75%
Antitumor Chemotherapeutic Agents
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Arjmand, F., I. Yousuf, Y. Zaidi and L. Toupet, 2015. Crystal structure determination, spectroscopic characterization and biological profile of tailored antitumor ionic drug entity, Sn(IV) iminodiacetic acid-piperazinediium conjugate: In vitro DNA and RNA binding studies, Topo I inhibition, cytotoxic activity and systemic toxicity studies. RSC Adv., 5: 16250-16264.
  2. Alizadeh, R., I. Yousuf, M. Afzal, S. Srivastav, S. Srikrishna and F. Arjmand, 2015. Enantiomeric fluoro-substituted benzothiazole Schiff base-valine Cu(II)/Zn(II) complexes as chemotherapeutic agents: DNA binding profile, cleavage activity, MTT assay and cell imaging studies. J. Photochem. Photobiol. B: Biol., 143: 61-73.
    Direct Link  |  
  3. Zaidi, Y., F. Arjmand, N. Zaidi, J. Usmani and H. Zubair et al., 2014. A comprehensive biological insight of trinuclear copper(II)-tin(IV) chemotherapeutic anticancer drug entity: In vitro cytotoxicity and in vivo systemic toxicity studies. Metallomics, 6: 1469-1479.
    Direct Link  |  
  4. Tabassum, S., S. Yadav and F. Arjmand, 2014. Exploration of glycosylated-organotin(IV) complexes as anticancer drug candidates. Inorg. Chim. Acta, 423: 38-45.
    Direct Link  |  
  5. Tabassum, S., M. Zaki, M. Afzal, M. Ahmad, S. Srivastav, S. Srikrishna and F. Arjmand, 2014. Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studies. Eur. J. Med. Chem., 83: 141-154.
    Direct Link  |  
  6. Tabassum, S., M. Zaki, M. Afzal and F. Arjmand, 2014. Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: In vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines. Eur. J. Med. Chem., 74: 509-523.
    Direct Link  |  
  7. Tabassum, S., M. Afzal and F. Arjmand, 2014. New modulated design, docking and synthesis of carbohydrate-conjugate heterobimetallic CuII-SnIV complex as potential topoisomerase II inhibitor: In vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines. Eur. J. Med. Chem., 74: 694-702.
    Direct Link  |  
  8. Shamsi, M., S. Yadav and F. Arjmand, 2014. Synthesis and characterization of new transition metal {Cu(II), Ni(II) and Co(II)} L-phenylalanine-DACH conjugate complexes: In vitro DNA binding, cleavage and molecular docking studies. J. Photochem. Photobiol. B, Biol., 136: 1-11.
    Direct Link  |  
  9. Parveen, S. and F. Arjmand, 2014. Enantiomeric in vitro DNA binding, pBR322 DNA cleavage and molecular docking studies of chiral L-and D-ternary copper(II) complexes of histidine and picolinic acid. J. Photochem. Photobiol. B, 130: 170-178.
    PubMed  |  
  10. Khan, R.A., S. Yadav, Z. Hussain, F. Arjmand and S. Tabassum 2014. Carbohydrate linked organotin(IV) complexes as human topoisomerase Iα inhibitor and their antiproliferative effects against human carcinoma cell line. Dalton Trans., 43: 2534-2548.
    PubMed  |  
  11. Khan, R.A., F. Arjmand, S. Tabassum, M. Monari, F. Marchetti and C. Pettinari, 2014. Organometallic Ruthenium(II) Scorpionate as Topo II inhibitor; in vitro binding studies with DNA, HPLC analysis and its anticancer activity. J. Organomet. Chem., 771: 47-58.
    Direct Link  |  
  12. Arjmand, F., S. Parveen, S. Tabassum and C. Pettinari, 2014. Organo-tin antitumor compounds: Their present status in drug development and future perspectives. Inorg. Chim. Acta, 423: 26-37.
    Direct Link  |  
  13. Arjmand, F., M. Muddassir and I. Yousuf, 2014. Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: Their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies. J. Photochem. Photobiol. B, 136: 62-71.
    Direct Link  |  
  14. Arjmand, F., I. Yousuf, T. Ben Hadda and L. Toupet, 2014. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: Comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies. Eur. J. Med. Chem., 81: 76-88.
    Direct Link  |  
  15. Arjmand, F., I. Yousuf, M. Afzal and L. Toupet, 2014. Design and synthesis of new Zn(II) nalidixic acid-DACH based Topo-II inhibiting molecular entity: Chemotherapeutic potential validated by its in vitro binding profile, pBR322 cleavage activity and molecular docking studies with DNA and RNA molecular targets. Inorg. Chm. Acta, 421: 26-37.
    Direct Link  |  
  16. Alizadeh, R., M. Afzal and F. Arjmand, 2014. In vitro DNA binding, pBR322 plasmid cleavage and molecular modeling study of chiral benzothiazole Schiff-base-valine Cu(II) and Zn(II) complexes to evaluate their enantiomeric biological disposition for molecular target DNA. Spectrochimica Acta A, 131: 625-635.
    Direct Link  |  
  17. Tabassum, S., S. Yadav and F. Arjmand, 2013. Synthesis and mechanistic insight of glycosylated CuII/NiII-Sn2IV heterobimetallic DNA binding agents: Validation of a specific CuII-Sn2IV chemotherapeutic agent for human leukemic cell line K-562. J. Organomet. Chem., 745-746: 226-234.
    Direct Link  |  
  18. Tabassum, S., S. Amir, F. Arjmand, C. Pettinari and F. Marchetti et al., 2013. Mixed-ligand cu(II)-vanillin schiff base complexes: Effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity. Eur. J. Med. Chem., 60: 216-232.
    Direct Link  |  
  19. Tabassum, S., M. Zaki, M. Afzal and F. Arjmand, 2013. New modulated design and synthesis of quercetin-CuII/ZnII-Sn2IV scaffold as anticancer agents: In vitro DNA binding profile, DNA cleavage pathway and Topo-I activity. Dalton Trans., 42: 10029-10041.
    CrossRef  |  PubMed  |  Direct Link  |  
  20. Tabassum, S., A. Asim, R.A. Khan, Z. Hussain, S. Srivastav, S. Srikrishna and F. Arjmand, 2013. Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα. Dalton Trans., 42: 16749-16761.
    PubMed  |  
  21. Sarkar, A., A.R. Paital, R.A. Khan, F. Arjmand and V. Bertolasi et al., 2013. Ligand dependent self-assembly of hydroxido-bridged dicopper units templated by sodium ion. Dalton Trans., 42: 12495-12506.
    Direct Link  |  
  22. Khan, R.A., A. Asim, R. Kakkar, D. Gupta, V. Bagchi, F. Arjmand and S. Tabassum, 2013. A chloro-bridged heterobimetallic (η6-Arene)ruthenium-organotin complex as an efficient topoisomerase Iα inhibitor. Organometallics, 32: 2546-2551.
    CrossRef  |  Direct Link  |  
  23. Arjmand, F., S. Parveen, S. Parveen and M. Afzal, 2013. Chiral discrimination of metal-based chemotherapeutics Co(II), Cu(II) and Zn(II) towards the ultimate drug target-DNA. Chem. Biol. Interface, 3: 137-145.
    Direct Link  |  
  24. Arjmand, F., S. Parveen and D.K. Mohapatra, 2013. Zinc(II) complexes of Pro-Gly and Pro-Leu dipeptides: Synthesis, characterization, in vitro DNA binding and cleavage studies. J. Photochem. Photobiol. B. Biol., 126: 78-86.
    Direct Link  |  
  25. Arjmand, F., M. Muddassir, Y. Zaidi and D. Ray, 2013. Design, synthesis and crystal structure determination of dinuclear copper-based potential chemotherapeutic drug entity; in vitro DNA binding, cleavage studies and an evaluation of genotoxicity by micronucleus test and comet assay. Med. Chem. Comm., 4: 394-405.
    CrossRef  |  Direct Link  |  
  26. Arjmand, F., F. Sayeed, S. Parveen, S. Tabassum, A.S. Juvekar and S.M. Zingde, 2013. Design and synthesis of S- and R- enantiomers of [4-(2-hydroxy-1-phenylethylimino)pent-2-ol]dimethyltin(IV) and 2,2-dimethyl-4-phenyl-1,3,2-oxazastannolidine: In vitro and in vivo antitumor activity of their S-enantiomer against human tumor cell lines. Dalton Trans., 42: 3390-3401.
    Direct Link  |  
  27. Arjmand, F., A. Jamsheera and D.K. Mohapatra, 2013. Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes. J. Photochem. Photobiol. B Biol., 121: 75-85.
    Direct Link  |  
  28. Arjmand, F., A. Jamsheera and D.K. Mohapatra, 2013. Synthesis, DNA recognition and cleavage studies of novel tetrapeptide complexes, Cu(II)/Zn(II)-Ala-Pro-Ala-Pro. Spectrochimica Acta A, 108: 151-158.
    Direct Link  |  
  29. Arjmand, F. and I. Yousuf, 2013. In vitro DNA binding profile and antimicrobial studies of chromone Schiff base organotin(IV) complexes. J. Organomet. Chem., 743: 55-62.
  30. Tabassum, Z., M. Muddassir, O. Sulaiman and F. Arjmand, 2012. In-vitro DNA binding and cleavage studies with pBR322 of N,N-Bis(3β-acetoxy-5α-cholest-6-yl-idene)hydrazine (L). J. Lumin., 132: 2178-2181.
  31. Tabassum, S., W.M. Al-Asbahy, M. Afzal, M. Shamsi and F. Arjmand, 2012. DNA binding and cleavage studies of new sulfasalazine-derived dipeptide Zn(II) complex: Validation for specific recognition with 5'-TMP. J. Lumin., 132: 3058-3065.
    CrossRef  |  Direct Link  |  
  32. Tabassum, S., W.M. Al-Asbahy, M. Afzal, F. Arjmand and V. Bagchi, 2012. Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor. Dalton Trans., 41: 4955-4964.
    Direct Link  |  
  33. Tabassum, S., W.M. Al-Asbahy, M. Afzal, F. Arjmand and R.H. Khan, 2012. Interaction and photo-induced cleavage studies of copper based chemotherapeutic drug with human serum albumin: Spectroscopic and molecular docking study. Mol. BioSyst., 8: 2424-2433.
    CrossRef  |  Direct Link  |  
  34. Tabassum, S., W.M. Al-Asbahy, M. Afzal and F. Arjmand, 2012. Synthesis, characterization and interaction studies of copper based drug with Human Serum Albumin (HSA): Spectroscopic and molecular docking investigations. J. Photochem. Photobiol. B: Biol., 114: 132-139.
    CrossRef  |  Direct Link  |  
  35. Tabassum, S., S. Mathur, F. Arjmand, K. Mishra and K. Banerjee, 2012. Design, synthesis, characterization and DNA-binding studies of a triphenyltin(IV) complex of N-glycoside (GATPT), a sugar based apoptosis inducer: in vitro and in vivo assessment of induction of apoptosis by GATPT. Metallomics, 4: 205-217.
    CrossRef  |  Direct Link  |  
  36. Tabassum, S., M. Zaki, F. Arjmand and I. Ahmad, 2012. Synthesis of heterobimetallic complexes: In vitro DNA binding, cleavage and antimicrobial studies. J. Photochem. Photobiol. B Biol., 114: 108-118.
    Direct Link  |  
  37. Tabassum, S., G.C. Sharma and F. Arjmand, 2012. New modulated design and synthesis of chiral CuII/SnIV bimetallic potential anticancer drug entity: in-vitro DNA binding and pBR322 DNA cleavage activity. Spectrochimica Acta Part A, 90: 208-217.
    Direct Link  |  
  38. Tabassum, S., A. Asim, F. Arjmand, M. Afzal and V. Bagchi, 2012. Synthesis and characterization of copper(II) and zinc(II)- based potential chemotherapeutic compounds: Their biological evaluation viz. DNA binding profile, cleavage and antimicrobial activity. Eur. J. Med. Chem., 58: 308-316.
    Direct Link  |  
  39. Parveen, S. and F. Arjmand, 2012. De novo design, synthesis and spectroscopic characterization of chiral benzimidazole-derived amino acid Zn(II) complexes: Development of tryptophan-derived specific hydrolytic DNA artificial nuclease agent. Spectrochim. Acta Part A, 85: 53-60.
    Direct Link  |  
  40. Arjmand, F., S. Parveen, M. Afzal, L. Toupet and T. Ben Hadda, 2012. Molecular drug design, synthesis and crystal structure determination of CuII-SnIV heterobimetallic core: DNA binding and cleavage studies. Eur. J. Med. Chem., 49: 141-150.
    Direct Link  |  
  41. Arjmand, F., S. Parveen, M. Afzal and M. Shahid, 2012. Synthesis, characterization, biological studies (DNA binding, cleavage, antibacterial and topoisomerase I) and molecular docking of copper(II) benzimidazole complexes. J. Photochem. Photobiol. B: Biol., 114: 15-26.
    Direct Link  |  
  42. Arjmand, F., S. Parveen and D.K. Mohapatra, 2012. Synthesis, characterization of Cu(II) and Zn(II) complexes of proline-glycine and proline-leucine tetrapeptides: In vitro DNA binding and cleavage studies. Inorg. Chim. Acta, 388: 1-10.
    Direct Link  |  
  43. Arjmand, F., A. Jamsheera, M. Afzal and S. Tabassum, 2012. Enantiomeric specificity of biologically significant Cu(II) and Zn(II) chromone complexes towards DNA. Chirality, 24: 977-986.
    Direct Link  |  
  44. Arjmand, F. and S. Parveen, 2012. Enantiomeric recognition of chiral L- and D-penicillamine Zinc(II) complexes: DNA binding behavior and cleavage studies. RSC Adv., 2: 6354-6362.
    CrossRef  |  Direct Link  |  
  45. Tak, A.A. and F. Arjmand, 2011. Synthesis of diketo copper(II) complex and its binding toward calf thymus DNA (CTDNA). J. Kor. Chem. Soc., 55: 177-182.
    Direct Link  |  
  46. Tabassum, S., R.A. Khan, F. Arjmand, S. Sen, J. Kayal, A.S. Juvekar and S.M. Zingde, 2011. Synthesis and characterization of Glycoconjugate Tin(IV) complexes: In vitro DNA binding studies, Cytotoxicity and cell death. J. Organomet. Chem., 696: 1600-1608.
    Direct Link  |  
  47. Tabassum, S., R.A. Khan, F. Arjmand, M. Aziz, A.S. Juveka, S. Sen and S.M. Zingde, 2011. Carbohydrate-conjugate heterobimetallic complexes: Synthesis, DNA binding studies, artificial nuclease activity and in-vitro cytotoxicity. Carbohydrate Res., 346: 2886-2895.
    PubMed  |  
  48. Arjmand, F., M. Aziz and S. Tabassum, 2011. Cyclic voltammetry-An electrochemical approach to study metal-based potential antitumor drug-DNA interaction. Curr. Anal. Chem., 7: 71-79.
    Direct Link  |  
  49. Arjmand, F., G.C. Sharma, M.M. and S. Tabassum, 2011. Synthesis and enantiopreferential DNA binding profile of late 3d transition metal R- and S-enantiomeric complexes derived from N, N-bis-(1-benzyl-2-ethoxyethane): Validation of R- enantiomer of copper(II) complex as a humantopoisomerase II inhibitor. Chirality, 23: 557-567.
  50. Arjmand, F., G.C. Sharma, F. Sayeed and M. Muddassir and S. Tabassum, 2011. De novo design of chiral organotin cancer drug candidates: Validation of enantiopreferential binding to molecular target DNA and 5'-GMP by UV-visible, Fluorescence, 1H and 31P NMR. J. Photochem. Photobiol. B Biol., 105: 167-174.
    Direct Link  |  
  51. Arjmand, F., F.S. Mohd and M. Muddassir, 2011. Synthesis of new chiral heterocyclic Schiff base modulated Cu(II)/Zn(II) complexes: Their comparative binding studies with CT-DNA, mononucleotides and cleavage activity. J. Photochem. Photobiol.B Biol., 103: 16-179.
    Direct Link  |  
  52. Arjmand, F., F. Sayeed and S. Parveen, 2011. In vitro binding studies of organotin(IV) complexes of 1,2-Bis(1H-benzimidazol-2-yl)ethane-1,2-diol with CT-DNA and nucleotides (5'-GMP and 5'-TMP): Effect of the ancillary ligand on the binding propensity. J. Organomet. Chem., 696: 3839-3845.
    Direct Link  |  
  53. Arjmand, F. and M. Muddassir, 2011. A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: Cleavage and antitumor activity. Chirality, 23: 250-259.
    CrossRef  |  Direct Link  |  
  54. Arjmand, F. and M. Aziz, 2011. Design and synthesis of new metal based potent chemotherapeutic agents derived from 3-acetoacetyl-7-methyl-pyrano-[4,3-b]-pyran-2,5-dione: DNA binding profile and in vitro cytotoxic activity against different human cancer cell lines. Chem. Biol. Interface, 1: 135-160.
  55. Arjmand, F. and A. Jamsheera, 2011. Synthesis, characterization and in vitro DNA binding studies of Tin(IV) complexes of tert-butyl 1-(2-hydroxy-1-phenylethylamino)-3-methyl-1-oxobutan-2-yl carbamate. J. Organomet. Chem., 696: 3572-3579.
    Direct Link  |  
  56. Arjmand, F. and A. Jamsheera, 2011. DNA binding studies of new valine derived chiral complexes of Tin(IV) and Zirconium(IV). Spectro. Chim. Acta, A78: 45-51.
    Direct Link  |  
  57. Tabassum, S., G.C. Sharma, F. Arjmand and A. Azam, 2010. DNA interaction studies of new nano metal based anticancer agent: Validation by spectroscopic methods. Nanotechnology, Vo9l. 21. .
    Direct Link  |  
  58. Arjmand, F., P. Tewatia, M. Aziz and R.H. Khan, 2010. Interaction studies of a novel Co(II) based potential chemotherapeutic agent with Human Serum Albumin (HSA) employing biophysical techniques. Med. Chem. Res., 19: 794-807.
    CrossRef  |  Direct Link  |  
  59. Arjmand, F., M. Muddassir and R.H. Khan, 2010. Chiral preference of L-tryptophan derived metal-based antitumor agent of late 3d-metal ions (Co(II), Cu(II) and Zn(II)) in comparison to D and DL-tryptophan analogues: Their in-vitro reactivity towards CT DNA, 5'-GMP and 5'-TMP. Eur. J. Med. Chem., 45: 3549-3557.
    Direct Link  |  
  60. Arjmand, F. and F. Sayeed, 2010. Synthesis of carbohydrate conjugate heterobimetallic CuII-Sn2IV and ZnII-Sn2IV complexes; their interactions with CTDNA and nucleotides; DNA cleavage and in vitro cytotoxicity. Eur. J. Med. Chem., 45: 4797-4806.
    Direct Link  |  
  61. Tabassum, S., I.U.H. Bhat and F. Arjmand, 2009. Synthesis of new heterometallic macromolecules: Their DNA-binding, cleavage activity and in vitro model electrochemotherapy study. Spectrochim. Acta, 74: 1152-1159.
    Direct Link  |  
  62. Arjmand, F. and M. Aziz, 2009. Synthesis and characterization of dinuclear macrocyclic cobalt(II), copper(II) and zinc(II) complexes derived from 2,2,2',2'-S,S[bis(bis-N,S-2-thiobenzimidazolyloxalato-1,2-ethane)]: DNA binding and cleavage studies. Eur. J. Med. Chem., 44: 834-844.
    Direct Link  |  
  63. Arjmand, F. and M. Aziz, 2009. Synthesis and biophysical studies of bis-macrocyclic cobalt/copper (II) complexes having pyridine spacer with CT DNA and 5' GMP. Chem. Biodivers., 6: 2275-2289.
    CrossRef  |  Direct Link  |  
  64. Arjmand, F., M. Aziz and M. Chauhan, 2008. Synthesis, Spectroscopic Studies of New Water-Soluble Co(II) and Cu(II) Macrocyclic complexes of 4,15-bis(2-hydroxyethyl)-2,4,6,13,15,17-hexaazatricyclodocosane: Their interaction studies with calf thymus DNA and guanosine 5' monophosphate. J. Inclusion Phenom. Macrocyclic Chem., 61: 265-278.
    CrossRef  |  Direct Link  |  
  65. Chauhan, M., K. Banerjee and F. Arjmand, 2007. DNA binding studies of novel copper (II) complexes containing L-tryptophan as chiral auxiliary: In vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells. Inorg. Chem., 46: 3072-3082.
    CrossRef  |  Direct Link  |  
  66. Chauhan, M. and F. Arjmand, 2007. Stannoxane capping derived from chiral tridentate NNO donor ligand for nickel and copper macrocycles: Comparative binding studies of stannoxane moiety and its modulated copper complex with CT DNA. J. Organomet. Chem., 692: 5156-5164.
    Direct Link  |  
  67. Mahajan, R.K., R. Kaur, S. Tabassum, F. Arjmand and S. Mathur, 2006. Cu(II) complexes as receptor molecules for development of new chloride sensors. Electrochimica Acta, 52: 408-414.
    Direct Link  |  
  68. Chauhan, M. and F. Arjmand, 2006. Chiral and achiral macrocyclic copper (II) complexes: Synthesis, characterization and comparative binding studies with calf thymus DNA. Chem. Biodivers., 3: 660-676.
    CrossRef  |  Direct Link  |  
  69. Tabassum, S., S. Parveen and F. Arjmand, 2005. Synthesis and characterization of new synthetic oxygen carriers. A kinetic studies of the reaction of the binuclear iron(III) and copper(II) complex with H2O2. Trans. Met. Chem., 30: 196-204.
    CrossRef  |  Direct Link  |  
  70. Tabassum, S., S. Parveen and F. Arjmand, 2005. New modulated metallic macrocycles: Electrochemistry and their interaction with calf thymus DNA. Acta Biomaterialia, 1: 677-689.
    Direct Link  |  
  71. Parveen, S. and F. Arjmand, 2005. Interaction of calf thymus DNA with new asymmetric copper(II) N,N-ethane bridged N2S2 macrocycle. Indian J. Chem., 44: 1151-1158.
    Direct Link  |  
  72. Chauhan, M. and F. Arjmand, 2005. Synthesis, characterization and interaction of a new chiral trinuclear complex [bis(aquodiaminotryptophanato)CuII-Sn2IV] chloride with calf thymus DNA. Trans. Met. Chem., 30: 481-487.
    Direct Link  |  
  73. Arjmand, F., S. Parveen and S. Tabassum, 2005. Synthesis of new dinuclear dicopper(II) and dinickel(II) complexes: Kinetics of catechol oxidase and electrochemistry of dicopper(II) complex. Trans. Met. Chem., 30: 128-135.
    CrossRef  |  Direct Link  |  
  74. Arjmand, F., B. Mohani and S. Ahmad, 2005. Synthesis, antibacterial, antifungal activity and interaction of CT-DNA with a new bezimidazole derived Cu(II) complex. Eur. J. Med. Chem., 40: 1103-1110.
    Direct Link  |  
  75. Arjmand, F. and M. Chauhan, 2005. Binding studies of asymmetric pentacoordinate Cu(II) complexes containing phenanthroline and ethylenediamine moiety with calf thymus DNA. Helvetica Chimica Acta, 88: 2413-2423.
    CrossRef  |  Direct Link  |  
  76. Tak, A.A., F. Arjmand and S. Tabassum, 2002. Synthesis, characterization, electrochemistry and kinetics of CTDNA binding of a bis ciprofloxacin borate copper(II) complex. Trans. Met. Chem., 27: 741-747.
    CrossRef  |  Direct Link  |  
  77. Tak, A.A., F. Arjmand and S. Tabassum, 2002. Synthesis of new five coordinated copper(II) and nickel(II) complexes of L- valine and kinetic study of copper(II) with calf thymus DNA. Metal Based Drugs, 9: 81-90.
    Direct Link  |  
  78. Mohani, B., F. Arjmand and S. Tabassum, 2002. New metal compounds and their reactivity towards bovine milk casein. Trans. Met. Chem., 27: 776-781.
    CrossRef  |  Direct Link  |  
  79. Tabassum, S., S.H. Rafiqi, N. Nishat, F. Arjmand and S. Srivastava, 2001. Synthesis and characterization of heterobimetallic complexes of 1,8-dihydro- 1,3,6,8,10,13 Hexaazacyclotetradecane with Cu(II), Ni(II), Si(IV), Ge (IV) and Sn(IV)Chlorides. Indian J. Chem., 40: 1237-1239.
    Direct Link  |  
  80. Tabassum, S., N.P. Singh and F. Arjmand, 2001. Synthesis, characterization and toxicity of heterobinuclear complexes of transition metal ions. Synth. React. Inorg. Met. Org. Chem., 31: 1803-1815.
    CrossRef  |  Direct Link  |  
  81. Athar, F., F. Arjmand and S. Tabassum, 2001. Novel asymmetric heterobimetallic complexes of transition metals and kinetics of oxygen binding to cobalt (II) complex. Trans. Met. Chem., 26: 574-580.
    Direct Link  |  
  82. Athar, F., F. Arjmand and S. Tabassum, 2001. New asymmetric N2S2 macrocycles, their metal chelates and the photokinetics of DNA-complex interaction. Trans. Met. Chem., 26: 426-429.
    CrossRef  |  Direct Link  |  
  83. Arjmand, F. and F. Athar, 2001. Synthesis and characterization of novel chiral organotin complexes. Indian J. Chem., 40: 213-215.
    Direct Link  |  

© All rights reserved | Design By: LiveDNA Member since October, 2015
Record last modified Jul 25, 2022, 10:14 am